Stock Information

• Vertex Posts Positive Phase II Data on Kidney Disease Drug
  Wed, Sep 23, 2026 4:08 PM
• AstraZeneca's Trixeo Secures Approval for Asthma in the EU
  Wed, Sep 23, 2026 3:00 PM
• AbbVie's Rinvoq Wins EU Approval in Juvenile Idiopathic Arthritis
  Tue, Sep 22, 2026 4:17 PM
• Novo's CagriSema Outshines Zepbound in Key Phase III Weight-Loss Study
  Tue, Sep 22, 2026 3:00 PM
• AZN's Klygefa Gets CHMP Nod for Generalised Myasthenia Gravis in EU
  Mon, Sep 21, 2026 5:29 PM
• Novo's Sogroya Gains CHMP Nod for Idiopathic Short Stature in the EU
  Mon, Sep 21, 2026 2:59 PM
• Novo's Denecimig Gets CHMP Nod for Hemophilia A in the European Union
  Fri, Sep 18, 2026 4:09 PM
• XENE Files NDA for Epilepsy Drug, Falls on Depression Studies' Setback
  Fri, Sep 18, 2026 3:09 PM
• RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy
  Fri, Sep 18, 2026 2:49 PM
• Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
  Thu, Sep 17, 2026 4:13 PM

Financial data not available